Supporting you with clinical trial patient engagement strategies to drive success

The ability to recruit enough patients into your study, and retain them, is vital to its success, but around 80% of sponsors say finding eligible patients is a significant barrier*. And delays can be expensive, potentially costing tens of thousands of pounds per day.

Our clinical trial patient engagement strategies aim to save you time – and ultimately money – by identifying which patients you need for your study, where to find them and how best to speak to them. We put the patient perspective first and create materials that will educate and interest them, and answer their most pressing questions.

We help prospective participants understand what’s involved in clinical research and ensure they give informed consent. And we work with you to make sure they remain part of the study for its duration, ensuring clinical trial success.

*Clinical Trials Transformation Initiative. Moving Recruitment Planning Upstream to Reduce Barriers to Participation: Recommendations from the CTTI Recruitment Planning Project. Presented at SCOPE Summit, 2017

Responding to Covid-19

Globally, patient recruitment into clinical trials has changed. The industry is starting to reopen sites and countries to enrolment, however due to the impact of the pandemic, many sites may require additional support to achieve enrolment targets.

How can Innovative Trials help?

With over 10 years experience as a global provider of patient recruitment and retention services in over 50 countries globally, we have launched our Site Recruitment Needs Assessment. This new service has been developed to support the industry to establish a baseline of the site’s recruitment status, which takes into consideration how COVID-19 has impacted the patient recruitment funnel. 

Once newly discovered recruitment constraints at the protocol, patient and operational level are assessed, your site and study team will be equipped with site, country and global level insights to further optimise enrolment for the project. A recommendations report will be provided to get you started, however we are also able to come along on the journey to support the implementation of the plan.

What’s included in the Recruitment Needs Assessment?

For more information on how we can help you respond to the current situation and plan for getting your clinical trials back on track please get in touch info@innovativetrials.com

Finding the right patients for your trial

Raising awareness and increasing access to clinical trials

We believe a major barrier to recruitment is a lack of awareness of clinical trials opportunities – something we’re actively trying to change. Our methods include working with patient advocacy groups, conducting community outreach, using online channels and creating unique patient-centric materials to tell people about your specific study.

Supporting sites with clinical trial patient engagement

Bespoke materials and support to help drive study success

We specialise in creating materials for patients that are informative, motivating and culturally and therapeutically relevant. This can range from printed booklets to animations and interactive content guides.

We also support site staff, developing printed and digital materials to help them with the recruitment process and study management.

Our services in this area include:

  • project management
  • brand development
  • technical and medical writing
  • translation services
  • print services
  • dedicated informed consent and participation support services
  • web pre-screener development

Increasing patient diversity

Promoting the inclusion of diverse patient populations in clinical research

It’s imperative that clinical trials involve those who will benefit most from the treatments being developed. However, there is a recognised under-representation of black, Asian and minority ethnic (BAME) communities within clinical research. 

In the UK, 14 percent of the population are of BAME or mixed ethnicity, but one research study found that only around five percent of people from BAME groups in the UK who were surveyed, had ever participated in medical research (1). It’s a similar picture in the US: African Americans account for 12 percent of the population, but only around five percent are involved in research (2)

The reasons for this under-representation are complex, including Issues such as cultural barriers and lack of knowledge of clinical trials (3). It is a significant issue – without diverse patient representation, medicines may not be as effective in some population groups and one we are focused on addressing.

Read more
(1) Harrison, E. K. & Smart, A. (2016). The under-representation of minority ethnic groups in UK medical research. Ethnicity and Health, doi: 10.1080/13557858.2016.1182126 http://openaccess.city.ac.uk/14545/ (2) Data presented by P. Sanders in “Dialogues on Diversifying Clinical Trials,” Washington, D.C., 2011 Sept 22. http://www.womenshealthresearch.org/site/PageServer?pagename=events_clinicaltrials  (3)RP Symonds et al. Recruitment of ethnic minorities into cancer clinical trials: experience from the front lines. British Journal of Cancer. 2012. 107(7): 1017–1021. Doi: 10.1038/bjc.2012.240

Patient advocacy

Engaging patient advocacy groups to reach potential clinical trial participants

We build relationships and partnerships with patient advocacy groups because we know how important this can be in raising awareness of clinical trials. We have the ability to do this at a national and local level in more than 55 countries.

Our services in this area include:

  • patient advocacy group research and engagement planning at both country and site level
  • community outreach with national and local groups
  • study materials to inform and engage patient advocacy groups
  • contact and follow-up with patient groups tailored to their country and language
  • research and surveys with patient group members

To find out how others have benefited from our support, take a look at our Case Studies.

Need support to recruit patients to your clinical trial?
Contact us to find out how we can help you.


Therapy Areas

We have extensive experience of study phases Ib to IV, adults and paediatrics and both acute and chronic conditions.

  • Intra abdominal pain
  • Post operative pain
  • Non Alcoholic Fatty Liver Disease (NAFLD)
  • Non Alcoholic steatohepatitis (NASH)
  • Hypercholesterolaemia
  • Type II Diabetes
  • Anaemia
  • Haemophilia
  • Sickle Cell
  • Thrombocytopenia
  • Osteoarthritis
  • Atopic Dermatitis
  • Hidradenitis Suppurativa
  • Psoriasis
  • Crohn’s Disease
  • Ulcerative Colitis
  • Bacterial infection – Sepsis
  • C-Diff
  • Intra-abdominal infectious disease
  • Pneumonia
  • Ankylosing Spondylitis
  • Alopecia
  • Asthma
  • Atopic Dermatitis
  • Crohn’s Disease
  • Hidradenitis Suppurativa
  • Lupus
  • Nasal Polyps
  • Psoriasis
  • Psoriatic Arthritis
  • Rheumatoid Arthritis
  • Ulcerative Colitis
  • Vitiligo
  • Alzheimer’s Disease
  • Epilepsy
  • Depression
  • Duchenne Muscular Dystrophy (DMD)
  • Dyskinesia in Cerebral Palsy
  • Migraine
  • Multiple Sclerosis
  • Parkinson’s Disease
  • Schizophrenia
  • Acute Myeloid Leukaemia
  • Basal cell carcinoma
  • Bladder Cancer
  • Breast Cancer
  • Colorectal Cancer
  • Gastric Cancer
  • Head & Neck Cancer
  • Liver cancer
  • Lung Cancer
  • Lymphoma
  • Metastatic bone pain
  • Myelofibrosis
  • Mutant Tumours
  • Ovarian Cancer
  • Pancreatic Cancer
  • Prostate Cancer
  • Solid Tumour
  • Treatment Resistance post cancer treatment
  • Urothelial Cancer
  • Asthma
  • COPD
  • Over-active bladder
  • Pneumonia
  • Urinary Tract Infection
  • Birth control
  • Interstitial cystitis
  • STD Prevention
  • Urinary Tract Infection